About this trial
Low-glycemic index (GI) carbohydrates help prevent type 2 diabetes and cardiovascular disease by reducing postprandial glucose, insulin spikes, inflammation, and triglyceride synthesis. They improve weight, lipid profiles, and vascular health. Our study will compare functional low-GI vs. standard wholegrain carbs in a Mediterranean diet to assess their effect on the Triglycerides-Glucose Index, a marker of metabolic and cardiovascular risk, in subjects with suboptimal triglyceride levels.
Eligibility criteria
Qualifiers
Male or female aged ≥ 18 years
TG>150 mg/dL
Subjects who have the capability to communicate and to comply with the study's requirements.
Subjects agree to participate in the study and having dated and signed the informed consent form.
Disqualifiers
Gluten hypersensitivity/Coeliac disease diagnosis
BMI>30 kg/m2
Any preventive treatments (i.e. lipid-lowering drugs, antihypertensives) not stabilized in type and dose for at least 3 months
Any medical or surgical condition that would limit the patient adhesion to the study protocol.
Trial design
Treatments tested in this trial
- Altograno® Bakery Foods
- Standard Whole-Grain Bakery Foods